{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:59:52Z","timestamp":1785196792049,"version":"3.55.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.japh.2026.103149","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:44:19Z","timestamp":1779839059000},"page":"103149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the role of pharmacists in providing care with long-acting injectables for HIV and PrEP"],"prefix":"10.1016","volume":"66","author":[{"given":"Shreya","family":"Barde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5567-3830","authenticated-orcid":false,"given":"Rebecca","family":"Lahrman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3752-9296","authenticated-orcid":false,"given":"Jacquelyn","family":"Kissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teagan","family":"Vaughn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4607-7615","authenticated-orcid":false,"given":"Jennifer","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0381-9356","authenticated-orcid":false,"given":"Junan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7627-6519","authenticated-orcid":false,"given":"Laura E.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.japh.2026.103149_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/apc.2022.0192","article-title":"Pharmacist-involved antiretroviral stewardship programs in people living with HIV\/AIDS: a systematic review","volume":"37","author":"Ahmed","year":"2023","journal-title":"AIDS Patient Care STDS"},{"issue":"8","key":"10.1016\/j.japh.2026.103149_bib4","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/phar.2605","article-title":"Therapeutic review of cabotegravir\/rilpivirine long-acting antiretroviral injectable and implementation considerations at an HIV specialty clinic","volume":"41","author":"Howe","year":"2021","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.japh.2026.103149_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/apc.2023.0250","article-title":"Implementation of a pharmacist-led, long-acting, injectable cabotegravir\/rilpivirine program for HIV-1 at health system-based clinics in the New York Metropolitan Area","volume":"38","author":"Nguyen","year":"2024","journal-title":"AIDS Patient Care STDS"},{"issue":"4","key":"10.1016\/j.japh.2026.103149_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/15284336.2018.1511346","article-title":"Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: patient perspectives from the eclair trial","volume":"19","author":"Murray","year":"2018","journal-title":"HIV Clin Trials"},{"issue":"9","key":"10.1016\/j.japh.2026.103149_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26006","article-title":"Perspectives of people living with HIV-1 on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings: results from the customize hybrid III implementation-effectiveness study","volume":"25","author":"Garris","year":"2022","journal-title":"J Int AIDS Soc"},{"issue":"9","key":"10.1016\/j.japh.2026.103149_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26003","article-title":"Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a hybrid III implementation-effectiveness study (customize)","volume":"25","author":"Czarnogorski","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.japh.2026.103149_bib10","article-title":"Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: a population-based analysis","volume":"33","author":"Sullivan","year":"2024","journal-title":"Lancet Reg Health Am"},{"issue":"4","key":"10.1016\/j.japh.2026.103149_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/25787489.2020.1824718","article-title":"Identifying appropriate candidates for long-acting antiretroviral therapy: findings from a survey of health care providers in the Atlas-2M trial","volume":"21","author":"Murray","year":"2020","journal-title":"HIV Res Clin Pract"},{"issue":"1","key":"10.1016\/j.japh.2026.103149_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jac5.1373","article-title":"Medication access: policy and practice opportunities for pharmacists","volume":"4","author":"Sobeski","year":"2020","journal-title":"J Am Coll Clin Pharm"},{"issue":"17","key":"10.1016\/j.japh.2026.103149_bib14","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2146\/ajhp140727","article-title":"Outcomes of pharmacist-assisted management of antiretroviral therapy in patients with HIV infection: a risk-adjusted analysis","volume":"72","author":"Nevo","year":"2015","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"10.1016\/j.japh.2026.103149_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/apc.2018.0294","article-title":"The pharmacist's expanding role in HIV pre-exposure prophylaxis","volume":"33","author":"Farmer","year":"2019","journal-title":"AIDS Patient Care STDS"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319126001342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319126001342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:32:09Z","timestamp":1785195129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319126001342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1544319126001342"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2026.103149","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the role of pharmacists in providing care with long-acting injectables for HIV and PrEP","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2026.103149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"103149"}}